# Pre-operative Stereotactic Body Radiation Therapy for Pancreatic Adenocarcinoma With or Without CCX872-B

> **NCT03778879** · PHASE1,PHASE2 · WITHDRAWN · sponsor: **Alan Katz**

## Conditions studied

- Adenocarcinoma of the Pancreas
- Pancreas Cancer

## Interventions

- **DRUG:** CCX872-B

## Key facts

- **NCT ID:** NCT03778879
- **Lead sponsor:** Alan Katz
- **Sponsor class:** OTHER
- **Phase:** PHASE1,PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** WITHDRAWN
- **Start date:** 2019-08-01
- **Primary completion:** 2019-08-31
- **Final completion:** 2019-08-31
- **Target enrollment:** 0 (ACTUAL)
- **Why stopped:** CCX872-B will not be available in sufficient quantity to conduct the study.
- **Last updated:** 2019-07-19


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03778879

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03778879, "Pre-operative Stereotactic Body Radiation Therapy for Pancreatic Adenocarcinoma With or Without CCX872-B". Retrieved via AI Analytics 2026-06-24 from https://api.ai-analytics.org/clinical/NCT03778879. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*